Gregory Alan Korbel, SVP, Chief Business Officer at Aprea Therapeutics, Inc. (APRE), sold 32,960 shares at $4.97 ($164K) on 2021-09-20, disclosed to the SEC on 2021-09-22.
Open-market sale of $164k APRE by SVP, Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.97 | 27,500 | $137K | 83.4% |
| 2 | $4.98 | 5,460 | $27K | 16.6% |
| Total | $4.97 avg | 32,960 | $164K | 100% |
| Filing → |
| APRE | SELL | 2021-10-05 | $134K | — | Filing → |
| APRE | BUY | 2019-10-07 | $8K | — | Filing → |